Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 16, 2015
[ Mon, Nov 16th 2015
] - WOPRAI
[ Mon, Nov 16th 2015
] - WOPRAI
[ Mon, Nov 16th 2015
] - WOPRAI
Fri, November 13, 2015
[ Fri, Nov 13th 2015
] - WOPRAI
[ Fri, Nov 13th 2015
] - WOPRAI
Thu, November 12, 2015
[ Thu, Nov 12th 2015
] - WOPRAI
[ Thu, Nov 12th 2015
] - WOPRAI
[ Thu, Nov 12th 2015
] - WOPRAI
[ Thu, Nov 12th 2015
] - WOPRAI
[ Thu, Nov 12th 2015
] - WOPRAI
Wed, November 11, 2015
[ Wed, Nov 11th 2015
] - WOPRAI
[ Wed, Nov 11th 2015
] - WOPRAI
[ Wed, Nov 11th 2015
] - WOPRAI
[ Wed, Nov 11th 2015
] - WOPRAI
[ Wed, Nov 11th 2015
] - WOPRAI
Tue, November 10, 2015
[ Tue, Nov 10th 2015
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
Paul Matteis Maintained (ALNY) at Buy with Increased Target to $152 on, Nov 10th, 2015
Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $151 to $152 on, Nov 10th, 2015.
Paul has made no other calls on ALNY in the last 4 months.
There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $115 on, Friday, August 7th, 2015
This is the rating of the analyst that currently disagrees with Paul
- Rahul Jasuja of "FBR Capital" Initiated at Buy and Held Target at $180 on, Tuesday, August 11th, 2015
Similar Stocks and Investing Articles
[ Fri, Nov 06th 2015
] - WOPRAI
[ Mon, Aug 31st 2015
] - WOPRAI
[ Tue, Aug 11th 2015
] - WOPRAI
[ Tue, Nov 18th 2014
] - WOPRAI
[ Wed, Nov 05th 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 11th 2013
] - WOPRAI
[ Mon, Nov 11th 2013
] - WOPRAI
[ Thu, Nov 07th 2013
] - WOPRAI
[ Wed, Oct 02nd 2013
] - WOPRAI